Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recipharm has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery of Emla™ Patch to Japan.
read more
Wednesday, January 28, 2015
Recipharm, the leading contract development and manufacturing organisation (CDMO), is pleased to announce its readiness for serialisation and the successful completion of a complex serialisation project for China on behalf of one of its customers. A ...
read more
Further to the announcement on 18th April 2016 that Recipharm would acquire the pharma division of Kemwell’s Indian operation, the Indian Foreign Investment Promotion Board has now granted approval for this transaction to take place.
read more
Tuesday, October 09, 2018
Recipharm has released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.
read more
Recipharm announced new product development contracts leveraging its Blow-Fill-Seal (BFS) technology.
read more
Tuesday, November 10, 2015
Recipharm has signed an agreement with Daewoong, a leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year extension of its existing contract, through to 2025, for the manufacture and supply of ...
read more
The company earmarks new EUR 90 million loan facility for further acquisition of niche CDMOs, investment in existing facilities and building long term partnerships with major pharmaceuticals companies.
read more
Wednesday, August 26, 2015
Recipharm AB has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma Ltd for the manufacturing of RedHill’s leading, late-stage patented drug candidate, RHB-105.
read more
Wednesday, September 20, 2017
Recipharm has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products.
read more
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more
Wednesday, December 23, 2015
Recipharm has entered into the previously announced strategic collaboration with Alcon, a Novartis company, and has signed a long term supply agreement whereby Recipharm will manufacture a range of ophthalmic products using Blow Fill Seal technology.
read more
Thursday, October 20, 2022
Recipharm has invested in a new high-speed filling line for pre-filled syringes and cartridges at its facility in Wasserburg, Germany responding to increased customer demand in these high-growth fill formats.
read more
Friday, December 20, 2013
RPH Pharmaceuticals AB, a subsidiary of Recipharm AB, announces the filing of an application for an infectious disease drug product in a range of European countries. The product has been developed through a partnership with Swedish pharmaceutical ...
read more
Wednesday, February 13, 2013
Recipharm and PledPharma announce FDA approval of an IND application for Phase IIb clinical trial with PledOx, PLIANT, in the U.S. The material for PLIANT has been manufactured by Recipharm Pharmaceutical Development.
read more
Wednesday, February 24, 2016
Recipharm AB has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialized in the filling of injectable beta lactam products. It ...
read more